-
Je něco špatně v tomto záznamu ?
Multimarker screening of oxidative stress in aging
K. Syslová, A. Böhmová, M. Mikoška, M. Kuzma, D. Pelclová, P. Kačer,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
Grantová podpora
NT13299
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Free Medical Journals
od 2008
Hindawi Publishing Open Access
od 2008-01-01
PubMed Central
od 2008
Europe PubMed Central
od 2008
ProQuest Central
od 2014-01-01
Open Access Digital Library
od 2008-01-01
Open Access Digital Library
od 2008-01-01
Open Access Digital Library
od 2009-01-01
Medline Complete (EBSCOhost)
od 2011-01-01
Health & Medicine (ProQuest)
od 2014-01-01
PubMed
25147595
DOI
10.1155/2014/562860
Knihovny.cz E-zdroje
- MeSH
- biologické markery metabolismus MeSH
- dinoprost analogy a deriváty metabolismus MeSH
- guanosin analogy a deriváty metabolismus MeSH
- lidé MeSH
- oxidační stres * MeSH
- poškození DNA MeSH
- proteiny chemie metabolismus MeSH
- stárnutí * MeSH
- tyrosin analogy a deriváty metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Aging is a complex process of organism decline in physiological functions. There is no clear theory explaining this phenomenon, but the most accepted one is the oxidative stress theory of aging. Biomarkers of oxidative stress, substances, which are formed during oxidative damage of phospholipids, proteins, and nucleic acids, are present in body fluids of diseased people as well as the healthy ones (in a physiological concentration). 8-iso prostaglandin F2α is the most prominent biomarker of phospholipid oxidative damage, o-tyrosine, 3-chlorotyrosine, and 3-nitrotyrosine are biomarkers of protein oxidative damage, and 8-hydroxy-2(')-deoxyguanosine and 8-hydroxyguanosine are biomarkers of oxidative damage of nucleic acids. It is thought that the concentration of biomarkers increases as the age of people increases. However, the concentration of biomarkers in body fluids is very low and, therefore, it is necessary to use a sensitive analytical method. A combination of HPLC and MS was chosen to determine biomarker concentration in three groups of healthy people of a different age (twenty, forty, and sixty years) in order to find a difference among the groups.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15014092
- 003
- CZ-PrNML
- 005
- 20190827093902.0
- 007
- ta
- 008
- 150420s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1155/2014/562860 $2 doi
- 035 __
- $a (PubMed)25147595
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Syslová, Kamila $u Institute of Chemical Technology, Technicka 5, 166 28 Prague 6, Czech Republic. $7 xx0145898
- 245 10
- $a Multimarker screening of oxidative stress in aging / $c K. Syslová, A. Böhmová, M. Mikoška, M. Kuzma, D. Pelclová, P. Kačer,
- 520 9_
- $a Aging is a complex process of organism decline in physiological functions. There is no clear theory explaining this phenomenon, but the most accepted one is the oxidative stress theory of aging. Biomarkers of oxidative stress, substances, which are formed during oxidative damage of phospholipids, proteins, and nucleic acids, are present in body fluids of diseased people as well as the healthy ones (in a physiological concentration). 8-iso prostaglandin F2α is the most prominent biomarker of phospholipid oxidative damage, o-tyrosine, 3-chlorotyrosine, and 3-nitrotyrosine are biomarkers of protein oxidative damage, and 8-hydroxy-2(')-deoxyguanosine and 8-hydroxyguanosine are biomarkers of oxidative damage of nucleic acids. It is thought that the concentration of biomarkers increases as the age of people increases. However, the concentration of biomarkers in body fluids is very low and, therefore, it is necessary to use a sensitive analytical method. A combination of HPLC and MS was chosen to determine biomarker concentration in three groups of healthy people of a different age (twenty, forty, and sixty years) in order to find a difference among the groups.
- 650 12
- $a stárnutí $7 D000375
- 650 _2
- $a biologické markery $x metabolismus $7 D015415
- 650 _2
- $a poškození DNA $7 D004249
- 650 _2
- $a dinoprost $x analogy a deriváty $x metabolismus $7 D015237
- 650 _2
- $a guanosin $x analogy a deriváty $x metabolismus $7 D006151
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a oxidační stres $7 D018384
- 650 _2
- $a proteiny $x chemie $x metabolismus $7 D011506
- 650 _2
- $a tyrosin $x analogy a deriváty $x metabolismus $7 D014443
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Böhmová, Adéla $u Institute of Chemical Technology, Technicka 5, 166 28 Prague 6, Czech Republic.
- 700 1_
- $a Mikoška, Miloš $u Institute of Chemical Technology, Technicka 5, 166 28 Prague 6, Czech Republic.
- 700 1_
- $a Kuzma, Marek, $u Institute of Chemical Technology, Technicka 5, 166 28 Prague 6, Czech Republic. $d 1974- $7 xx0075964
- 700 1_
- $a Pelclová, Daniela $u Department of Occupational Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Na Bojisti 1, 120 00 Prague 2, Czech Republic.
- 700 1_
- $a Kačer, Petr, $u Institute of Chemical Technology, Technicka 5, 166 28 Prague 6, Czech Republic. $d 1969- $7 xx0081992
- 773 0_
- $w MED00180520 $t Oxidative medicine and cellular longevity $x 1942-0994 $g Roč. 2014, č. - (2014), s. 562860
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25147595 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150420 $b ABA008
- 991 __
- $a 20190827094122 $b ABA008
- 999 __
- $a ok $b bmc $g 1071673 $s 896970
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 2014 $c - $d 562860 $i 1942-0994 $m Oxidative medicine and cellular longevity $n Oxid Med Cell Longev $x MED00180520
- GRA __
- $a NT13299 $p MZ0
- LZP __
- $a Pubmed-20150420